Research & Development

Handa excels in situations in which the brand is highly variable, has numerous patents, or provides bioequivalence challenges – the more difficult, the better

Commercializing difficult-to-formulate products translates into fewer competitors, less price erosion, and more sustainable profits

Two complementary applications of Handa’s intellectual property and techological expertise:

  • Low Risk, Patentable Specialty Pharmaceuticals
    • Leveraging 505(b)(2) NDA Pathway (U.S.)
    • Ten (10) month FDA review cycle
  • High Barrier Generics (ANDAs)
    • Formulation, legal, and/or manufacturing barriers

Additional detail: